Drug interactions
Escitalopram + Orphenadrine
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Additive CNS depression (sedation, dizziness, impaired psychomotor function) and a potential additive effect on QT prolongation, which may increase torsades de pointes risk in susceptible patients (e.g., baseline QT prolongation, electrolyte disturbances, structural heart disease, higher doses).
Mechanism of action
Pharmacodynamic: Orphenadrine has anticholinergic and antihistaminic sedative effects; escitalopram can contribute to CNS effects. Escitalopram prolongs QT via hERG blockade; orphenadrine has quinidine-like cardiac effects and has been associated with arrhythmias, suggesting possible QT effects.
Clinical management
Prefer alternatives in patients with significant QT risk. If coadministered: use lowest effective doses; avoid other QT‑prolonging agents and CNS depressants; obtain baseline and follow‑up ECG in patients with cardiac risk factors; correct hypokalemia/hypomagnesemia; counsel on sedation and falls; caution with driving or operating machinery.
Drug reference
References
- Escitalopram (Lexapro) Prescribing Information — FDA Label
- Orphenadrine citrate (Norflex) Prescribing Information — FDA Label
- Escitalopram: Drug information — Lexicomp
- Orphenadrine: Drug information — Lexicomp
Frequently asked questions
Can I take Escitalopram with Orphenadrine?
The interaction is rated: Moderate. Additive CNS depression (sedation, dizziness, impaired psychomotor function) and a potential additive effect on QT prolongation, which may increase torsades de pointes risk in susceptible patients (e.g., baseline QT prolongation, electrolyte disturbances, structural heart disease, higher doses).
How serious is the interaction between Escitalopram and Orphenadrine?
The interaction is rated: Moderate. Evidence level: Moderate.
How is the interaction between Escitalopram and Orphenadrine managed?
Prefer alternatives in patients with significant QT risk. If coadministered: use lowest effective doses; avoid other QT‑prolonging agents and CNS depressants; obtain baseline and follow‑up ECG in patients with cardiac risk factors; correct hypokalemia/hypomagnesemia; counsel on sedation and falls; caution with driving or operating machinery.
Why do Escitalopram and Orphenadrine interact?
Pharmacodynamic: Orphenadrine has anticholinergic and antihistaminic sedative effects; escitalopram can contribute to CNS effects. Escitalopram prolongs QT via hERG blockade; orphenadrine has quinidine-like cardiac effects and has been associated with arrhythmias, suggesting possible QT effects.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.